We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.105 | 2.26% | 4.755 | 4.52 | 4.99 | - | 189,060 | 16:35:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/6/2020 12:55 | Ay, we all get it wrong ;-) | itshenderz | |
01/6/2020 12:52 | Im going to make an offer...... DOnt think so | spartan attack | |
01/6/2020 12:51 | Dragons den "I burn 4.5m a year re cashburn. We were broke and made a placing. It all hinges on readouts soon and we beat the big guns. If we dont, cash dries up fairly fast.. We value our company at 50 million and want 25 millon investment for 50%. Our record is basically loss upon loss etc, and as insiders, we have put near zero in ourselves" | spartan attack | |
01/6/2020 12:48 | Excellent interview. Lots of interest in manufacture and if it works will likely expand very quickly. Add in as a preventitive.... I'll keep adding, whatever the shorter is saying. | waterloo01 | |
01/6/2020 12:48 | itshenderz 31 May '20 - 19:22 - 8468 of 8585 Things are hotting up here, for the first time in a while I reckon we're in for a solid week, good luck all holders, let's take this by the balls = = = = ...I'm guessing this all starts tomorrow - right? | 801710245 | |
01/6/2020 12:44 | What im trying to say is, if you read globally, the threads for example on all these type companies, the hope and expectation is same, based on whatever stage and uniqueness each has Well, thats a whole lot of companies, and it would be very lucky if one takes down the titans on this The odds against are astronomical in any of them. Ive looked for a decent etf in case one small in the niche hit the jackpot, to spread risk but to be honest, the weightings just killed the basket even if occured If you win here. Well done. It was against all possible odds | spartan attack | |
01/6/2020 12:40 | Market reality is dawning re Titan v small on the whole, the punt on small is ebbing away Most likely putting profit into Titans | spartan attack | |
01/6/2020 12:39 | Longterm, thanks for the link. New to me. | waterloo01 | |
01/6/2020 12:37 | Gilead different Not really a gamble. Plenty of product if that one turned out flat. They were not banking on it per se So the likes of Gilead, Merck and co, will get that boost on any news really. Seen as a conservative bet for big reward Not boom or bust | spartan attack | |
01/6/2020 12:36 | The link also confirms nobby's post below. | l0ngterm | |
01/6/2020 12:33 | Not sure if this has been posted, but gives a good overview, of where Are. (27th of may)From prof Stephen Holgate, Southampton Universityhttps://hs | l0ngterm | |
01/6/2020 12:32 | Waiting till mid June before buying any more | money4me | |
01/6/2020 12:29 | The size of the potential market increases! Of course it makes perfect sense because the first part of the COPD trial in patients with no infection showed their white blood cells started to express anti viral proteins! So essentially they were primed and ready to fight a viral infection in the lungs. | nobbygnome | |
01/6/2020 12:26 | I say, this paper suggests that INFA might actually aid prevention. That IFN dysregulation represents a key determinant of COVID-19 pathogenesis highlights its potential for therapeutic intervention. Prophylactic administration of IFNs, which elicits a pre-existing antiviral state in target cells, may block viral infection at the very early stage. Daily IFNα nasal drops along with standard personal protective equipment (PPE) were shown to protect at-risk health-care workers from COVID-19 over 28 days without noticeable adverse effects | waterloo01 | |
01/6/2020 12:15 | Saya Nobby - as she sinks since SA arrived 55/56 | spartan attack | |
01/6/2020 12:12 | >> ross Please don't engage the troll! Dialogue with him is pointless.... | nobbygnome | |
01/6/2020 12:09 | The Titans can even "marketing" you out of business if they had something only half as good. Lobby in full swing | spartan attack | |
01/6/2020 12:03 | 1 code for the believers ;-) | itshenderz | |
01/6/2020 11:50 | Yes you are correct it is 109 out of 120. I was confused by the protocol on clinical trials.gov which says the number of patients was going to be 130. Of course that number included the 10 in the first phase of the trial as I discussed above. Doh! | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions